Overview
Henry Kaplan is an Oncologist in Seattle, Washington. Dr. Kaplan is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Gastrostomy, and Bone Marrow Aspiration. Dr. Kaplan is currently accepting new patients.
His clinical research consists of co-authoring 55 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- PPO
- EPO
- PPO
- EPO
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
The Association Of University Physicians
Andrew Coveler is an Oncologist in Seattle, Washington. Dr. Coveler is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Pancreatectomy. Dr. Coveler is currently accepting new patients.
The Association Of University Physicians
Nicole Fleming is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Seattle, Washington. Dr. Fleming is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Ovarian Cancer, Testicular Yolk Sac Tumor, and Oophorectomy. Dr. Fleming is currently accepting new patients.
Northwest Medical Specialties PLLC
Ludmila Martin is an Oncologist in Gig Harbor, Washington. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Neuroendocrine Tumor.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Kaplan isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Kaplan isDistinguished. Learn about Angiosarcoma.
- Follicular LymphomaDr. Kaplan isDistinguished. Learn about Follicular Lymphoma.
- Inflammatory Breast CancerDr. Kaplan isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Kaplan isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Kaplan isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Kaplan isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Adult Soft Tissue SarcomaDr. Kaplan isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Chromophobe Renal Cell CarcinomaDr. Kaplan isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Kaplan isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Clear Cell SarcomaDr. Kaplan isAdvanced. Learn about Clear Cell Sarcoma.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Kaplan isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adenoid Cystic CarcinomaDr. Kaplan isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Kaplan isExperienced. Learn about Adrenal Cancer.
- AgranulocytosisDr. Kaplan isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Kaplan isExperienced. Learn about Anal Cancer.
- Angioimmunoblastic T-cell LymphomaDr. Kaplan isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.